{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:51Z","timestamp":1707524451890},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,26]]},"DOI":"10.7759\/cureus.19054","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T14:28:40Z","timestamp":1635258520000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiomyopathy Management and In-Hospital Outcomes in a Tertiary Care Center: Clinical Components and Venues of Advanced Care"],"prefix":"10.7759","author":[{"given":"Sheeren","family":"Khaled","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad M","family":"Babateen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal Y","family":"Alhodian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renad W","family":"AlQashqari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reema S","family":"AlZaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Almaimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine A","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawlah E","family":"Samarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani A","family":"Fallatah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott P","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E, et al.. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008, 29:270-6. 10.1093\/eurheartj\/ehm342","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention","volume":"113","author":"Maron BJ","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, et al.. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006, 113:1807-16. 10.1161\/CIRCULATIONAHA.106.174287","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron BJ","year":"1995","unstructured":"Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995, 92:785-9. 10.1161\/01.cir.92.4.785","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.54.3.388","article-title":"The coronary arteries and left ventricle in clinically isolated angina pectoris: a necropsy analysis","volume":"54","author":"Roberts WC","year":"1976","unstructured":"Roberts WC. The coronary arteries and left ventricle in clinically isolated angina pectoris: a necropsy analysis. Circulation. 1976, 54:388-90. 10.1161\/01.cir.54.3.388","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1576482","article-title":"Management of a patient with heart failure by sacubitril\/valsartan: improvement of functional capacity","volume":"35","author":"Paolini C","year":"2019","unstructured":"Paolini C, Perrone C, Pellizzari CA, Randon ML, Bilato C. Management of a patient with heart failure by sacubitril\/valsartan: improvement of functional capacity. Curr Med Res Opin. 2019, 35:7-8. 10.1080\/03007995.2019.1576482","journal-title":"Curr Med Res Opin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq407","article-title":"Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT","volume":"32","author":"Barsheshet A","year":"2011","unstructured":"Barsheshet A, Goldenberg I, Moss AJ, et al.. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J. 2011, 32:1622-30. 10.1093\/eurheartj\/ehq407","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang RM","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al.. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015, 28:1-39.e14. 10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90901-a","article-title":"Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop)","volume":"69","author":"Manolio TA","year":"1992","unstructured":"Manolio TA, Baughman KL, Rodeheffer R, et al.. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). American Journal of Cardiology. 1992, 69:1458-66. 10.1016\/0002-9149(92)90901-a","journal-title":"American Journal of Cardiology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott PM","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA, et al.. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014, 35:2733-79. 10.1093\/eurheartj\/ehu284","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2007.01336.x","article-title":"The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys","volume":"61","author":"Bays HE","year":"2007","unstructured":"Bays HE, Chapman RH, Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract. 2007, 61:737-47. 10.1111\/j.1742-1241.2007.01336.x","journal-title":"Int J Clin Pract"},{"key":"ref11","article-title":"Ischemic Cardiomyopathy","author":"Bhandari B","year":"2020","unstructured":"Bhandari B, Rodriguez BS, Masood W. Ischemic Cardiomyopathy. StatPearls Publishing, Treasure Island, FL; 2020."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5312","article-title":"Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study","volume":"6","author":"Fang CY","year":"2018","unstructured":"Fang CY, Chen HC, Chen YL, et al.. Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study. PeerJ. 2018, 6:e5312. 10.7717\/peerj.5312","journal-title":"PeerJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12944","article-title":"Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature","volume":"286","author":"Reichart D","year":"2019","unstructured":"Reichart D, Magnussen C, Zeller T, Blankenberg S. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature. J Intern Med. 2019, 286:362-72. 10.1111\/joim.12944","journal-title":"J Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.2016.1125292","article-title":"Clinical management of dilated cardiomyopathy: current knowledge and future perspectives","volume":"14","author":"Merlo M","year":"2016","unstructured":"Merlo M, Cannat\u00e1 A, Vitagliano A, Zambon E, Lardieri G, Sinagra G. Clinical management of dilated cardiomyopathy: current knowledge and future perspectives. Expert Rev Cardiovasc Ther. 2016, 14:137-40. 10.1586\/14779072.2016.1125292","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2019.10.006","article-title":"Myocardial deformation pattern differs between ischemic and non-ischemic dilated cardiomyopathy: the diagnostic value of longitudinal strains","volume":"46","author":"Zuo H","year":"2020","unstructured":"Zuo H, Zhang Y, Ma F, et al.. Myocardial deformation pattern differs between ischemic and non-ischemic dilated cardiomyopathy: the diagnostic value of longitudinal strains. Ultrasound Med Biol. 2020, 46:233-43. 10.1016\/j.ultrasmedbio.2019.10.006","journal-title":"Ultrasound Med Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-018-01515-3","article-title":"Myocardial segmental thickness variability on echocardiography is a highly sensitive and specific marker to distinguish ischemic and non-ischemic dilated cardiomyopathy in new onset heart failure","volume":"35","author":"Katikireddy CK","year":"2019","unstructured":"Katikireddy CK, Acharya T. Myocardial segmental thickness variability on echocardiography is a highly sensitive and specific marker to distinguish ischemic and non-ischemic dilated cardiomyopathy in new onset heart failure. Int J Cardiovasc Imaging. 2019, 35:791-8. 10.1007\/s10554-018-01515-3","journal-title":"Int J Cardiovasc Imaging"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the\u00a0Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy CW","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al.. 2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the\u00a0Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017, 70:776-803. 10.1016\/j.jacc.2017.04.025","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.05.005","article-title":"Sacubitril\/Valsartan in advanced heart failure with reduced ejection fraction: rationale\/design of the LIFE trial","volume":"8","author":"Mann DL","year":"2020","unstructured":"Mann DL, Greene SJ, Givertz MM, et al.. Sacubitril\/Valsartan in advanced heart failure with reduced ejection fraction: rationale\/design of the LIFE trial. JACC Heart Fail. 2020, 8:789-99. 10.1016\/j.jchf.2020.05.005","journal-title":"JACC Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000643","article-title":"Titration and tolerability of Sacubitril\/Valsartan for patients with heart failure in clinical practice","volume":"73","author":"Du AX","year":"2019","unstructured":"Du AX, Westerhout CM, McAlister FA, et al.. Titration and tolerability of Sacubitril\/Valsartan for patients with heart failure in clinical practice. J Cardiovasc Pharmacol. 2019, 73:149-54. 10.1097\/FJC.0000000000000643","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-07036-3","article-title":"Comparison of the effect of Sacubitril\/Valsartan on left ventricular systolic function in patients with non-ischaemic and ischaemic cardiomyopathy","volume":"34","author":"Ioannou A","year":"2020","unstructured":"Ioannou A, Metaxa S, Simon S, Mandal AK, Missouris CG. Comparison of the effect of Sacubitril\/Valsartan on left ventricular systolic function in patients with non-ischaemic and ischaemic cardiomyopathy. Cardiovasc Drugs Ther. 2020, 34:755-62. 10.1007\/s10557-020-07036-3","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2019.07.433","article-title":"Predictors of left ventricular function improvement in patients prescribed Sacubitril\/Valsartan in a tertiary-care community-based heart failure cohort","volume":"25","author":"Rao VU","year":"2019","unstructured":"Rao VU, Dobariya V, Patel K, et al.. Predictors of left ventricular function improvement in patients prescribed Sacubitril\/Valsartan in a tertiary-care community-based heart failure cohort. J Cardiac Fail. 2019, 25:150-10. 10.1016\/j.cardfail.2019.07.433","journal-title":"J Cardiac Fail"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1023\/B:JICE.0000035931.10063.50.","article-title":"Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia","volume":"11","author":"Evonich RF","year":"2004","unstructured":"Evonich RF, Maheshwari A, Gardiner JC, et al.. Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia. J Intervent Cardiac Electrophysiol. 2004, 11:59-65. 10.1023\/B:JICE.0000035931.10063.50.","journal-title":"J Intervent Cardiac Electrophysiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez EJ","year":"2011","unstructured":"Velazquez EJ, Lee KL, Deja MA, et al.. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011, 364:1607-16. 10.1056\/NEJMoa1100356","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003255","article-title":"Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease: a meta-analysis","volume":"10","author":"Wolff G","year":"2017","unstructured":"Wolff G, Dimitroulis D, Andreotti F, et al.. Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease: a meta-analysis. Circ Heart Fail. 2017, 10:e003255. 10.1161\/CIRCHEARTFAILURE.116.003255","journal-title":"Circ Heart Fail"},{"key":"ref25","article-title":"Dilated cardiomyopathy","author":"Mahmaljy H","year":"2020","unstructured":"Mahmaljy H, Yelamanchili VS, Singhal M. Dilated cardiomyopathy. StatPearls Publishing, Treasure Island, FL; 2020."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2019.07.200","article-title":"Patient characteristics and in-hospital outcomes of heart failure with ischemic versus non-ischemic cardiomyopathy","volume":"25","author":"Wu F","year":"2019","unstructured":"Wu F, Li P. Patient characteristics and in-hospital outcomes of heart failure with ischemic versus non-ischemic cardiomyopathy. J Cardiac Fail. 2019, 25:S70. 10.1016\/j.cardfail.2019.07.200","journal-title":"J Cardiac Fail"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S260256","article-title":"Predictors of mortality in patients with chronic heart failure: Is hyponatremia a useful clinical biomarker?","volume":"13","author":"Alem MM","year":"2020","unstructured":"Alem MM. Predictors of mortality in patients with chronic heart failure: Is hyponatremia a useful clinical biomarker?. Int J Gen Med. 2020, 13:407-17. 10.2147\/IJGM.S260256","journal-title":"Int J Gen Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20170136","article-title":"Causes and predictors of in-hospital mortality in patients admitted with or for heart failure at a tertiary hospital in Brazil","volume":"109","author":"Wajner A","year":"2017","unstructured":"Wajner A, Zuchinali P, Olsen V, Polanczyk CA, Rohde LE. Causes and predictors of in-hospital mortality in patients admitted with or for heart failure at a tertiary hospital in Brazil. Arq Bras Cardiol. 2017, 109:321-30. 10.5935\/abc.20170136","journal-title":"Arq Bras Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002962","article-title":"Changes in left ventricular ejection fraction predict survival and hospitalization in heart failure with reduced ejection fraction","volume":"9","author":"Breathett K","year":"2016","unstructured":"Breathett K, Allen LA, Udelson J, Davis G, Bristow M. Changes in left ventricular ejection fraction predict survival and hospitalization in heart failure with reduced ejection fraction. Circ Heart Fail. 2016, 9:e002962. 10.1161\/CIRCHEARTFAILURE.115.002962","journal-title":"Circ Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72792-cardiomyopathy-management-and-in-hospital-outcomes-in-a-tertiary-care-center-clinical-components-and-venues-of-advanced-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:51Z","timestamp":1707507351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72792-cardiomyopathy-management-and-in-hospital-outcomes-in-a-tertiary-care-center-clinical-components-and-venues-of-advanced-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.19054","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,26]]}}}